Therapy Areas: Oncology
18 September 2018 - - German radiopharmaceutical group Isotopen Technologien München AG has signed a Research Evaluation and Option Agreement for a worldwide exclusive license with German pharmac...
18 September 2018 - Immuno-oncology company Agenus Inc (NASDAQ:AGEN) on Monday announced that Incyte has made a cash milestone payment of USD5m for the initiation of its Phase 1 clinical trial of INCA...
18 September 2018 - Cancer immune-therapy company Tikcro Technologies Ltd (OTCQB:TIKRF) stated on Monday that it recorded a net loss of USD341,000 (USD0.03 per diluted share) for the second quarter en...
18 September 2018 - Biotechnology company Halozyme Therapeutics Inc (NASDAQ:HALO ) stated on Monday that it has Health Canada approval for a subcutaneous (SC) formulation of trastuzumab (Herceptin SC)...
18 September 2018 - Lin BioScience, a drug development company targeting untreatable conditions in oncology, ophthalmology and metabolic diseases, announced yesterday that the United States Food and D...
18 September 2018 - ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, announced yesterday that it has...